preclamol has been researched along with tetraethylammonium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henderson, G; Kennedy, C | 1 |
| Ekman, A; Eriksson, E; Hellstrand, M; Nilsson, CL | 1 |
2 other study(ies) available for preclamol and tetraethylammonium
| Article | Year |
|---|---|
Inhibition of potassium currents by the sigma receptor ligand (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine in sympathetic neurons of the mouse isolated hypogastric ganglion.
Topics: Animals; Atropine; Carbazoles; Dopamine Agents; Evoked Potentials; Ganglia, Sympathetic; In Vitro Techniques; Male; Membrane Potentials; Mice; Mice, Inbred DBA; Neurons; Piperidines; Potassium Channels; Receptors, Opioid; Receptors, sigma; Sulpiride; Tetraethylammonium; Tetraethylammonium Compounds; Tetrodotoxin | 1990 |
The intrinsic activity of (-)-3-PPP vis-à-vis prolactin-suppressing dopamine D2 receptors in transfected GH4C1 cells is dependent on which secretagogue that is used to provoke prolactin release.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Cell Line; Dopamine; Dopamine Agonists; Humans; Piperidines; Potassium; Prolactin; Receptors, Dopamine D2; Tetraethylammonium; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide | 1998 |